Read more at The New York Times.
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
Date: |
Topics
-
CNBC - Business
'Stop ripping us off': Novo Nordisk CEO defends weight loss drug pricing during Senate grilling
Sen. Bernie Sanders argues that Novo Nordisk charges Americans substantially higher prices for its drugs than it does for patients in other countries.50 minutes ago -
MarketWatch - Business
Fed’s Bowman says inflation remains a concern despite recent progress
“While it has not been my baseline outlook, I cannot rule out the risks that progress on inflation could continue to stall,” Fed Gov. Michelle Bowman said.2 hours ago -
The Hill - Politics
Watch live: Senate HELP committee grills Novo Nordisk on weight loss drug pricing
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor and Pensions (HELP) Committee, is set to grill Novo Nordisk CEO Lars Jorgenson Tuesday morning over prices on the ...3 hours ago -
CBS News - Top stories
Ozempic maker to testify before Senate committee on weight loss drug prices
Novo Nordisk CEO Lars Fruergaard Jørgensen is testifying before the Senate Health, Education, Labor and Pension committee on Tuesday.3 hours ago -
Financial Times - World
Inflation and interest rates tracker: see how your country compares
Inflationary pressures are beginning to wane but not all central banks have taken action yet. See how this affects you9 hours ago -
The Hill - Politics
Novo CEO to blame drug middlemen
Presented by Prevent Cancer Foundation — The CEO of Novo Nordisk will testify in the Senate HELP Committee tomorrow about the cost of popular diabetes and weight loss drugs Ozempic and Wegovy. ...19 hours ago -
Inc. - Business
The Fed Calls Inflation Fight a Success. When Will the Public Notice?
Polls show most Americans are still deeply unhappy about the economy, despite a slowdown in rising prices.Yesterday - Federal Reserve -
Financial Times - World
Novo Nordisk faces US Senate grilling over price of weight loss drugs
Senator Bernie Sanders accuses Ozempic and Wegovy maker of ‘ripping off’ AmericansYesterday -
Financial Times - World
Inflation-proofing pensions is no mean feat
A balanced portfolio has the best chance of preserving the long-term value of pension savings against price rise shocksYesterday -
CBS News - Top stories
FTC's Lina Khan on fighting for the underdog
Whether it's blocking big mergers, going after monopolies, or fighting daily consumer indignities, Federal Trade Commission Chair Lina Khan told 60 Minutes she fights for people who are being ...Yesterday -
CBS News - Top stories
Lina Khan: From FTC commissioner to chair in hours
Hours after the Senate confirmed Lina Khan to the Federal Trade Commission, President Biden named her FTC Chair at just 32 years old: "My arrival represented a lot of change."Yesterday -
CBS News - Top stories
FTC Chair Lina Khan wants to keep fighting non-competes
In an interview with 60 Minutes, the Federal Trade Commission head said the agency believes it has the authority to ban non-compete agreements — and will defend its case in court.Yesterday -
CBS News - Top stories
Kroger-Albertsons merger could raise grocery costs, FTC chair warns
Grocery chains Kroger and Albertsons want to merge. It's a move Federal Trade Commission Chair Lina Khan worries could hurt customers already dealing with high food costs.Yesterday -
CBS News - Top stories
FTC trustbuster Lina Khan: feared in boardrooms, cheered on by progressive
At the Federal Trade Commission, Chair Lina Khan's mission is breaking illegal monopolies, blocking mergers that stifle competition, and protecting consumers.Yesterday -
Inc. - Business
Drought Conditions Threaten Brazilian Coffee Pipeline, Prices
Brazil--the world's largest coffee producer--is grappling with the nation's worst drought in over seven decades.Yesterday - Brazil -
Financial Times - World
The path to global carbon pricing
To tackle climate change, the polluter pays principle needs to spread further and wider2 days ago -
CNBC - Business
FTC sues drug middlemen for allegedly inflating insulin prices
The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts.3 days ago -
CBS News - Top stories
Inflation concerns weigh heavily on voters
Many Americans are voting with their wallets this year, which is unsurprising considering the U.S. economy consistently polls as a top concern. Vice President Kamala Harris and former President ...3 days ago -
NBC News - Top stories
California firefighter accused of setting fires in wine country
A California firefighter was arrested on suspicion of arson in a series of small fires that burned in wine country in recent weeks, officials said Friday.3 days ago - California -
NBC News - Top stories
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.3 days ago -
ABC News - Health
An appeals court has revived a challenge to President Biden's Medicare drug price reduction program
A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for prescription drugs has been revived by a federal appeals court3 days ago - Joe Biden -
CBS News - Top stories
Drug middlemen illegally drive up the cost of insulin, FTC says
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.3 days ago -
BBC News - Top stories
Fayed was 'a monster enabled by Harrods', says accusers' lawyer
Lawyers representing victims say the store should "take responsibility" after sexual abuse allegations emerge.3 days ago -
ABC News - Health
High insulin prices spur a federal lawsuit against three pharmacy benefit managers
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for patients3 days ago -
The Hill - Politics
FTC sues three largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged anticompetitive practices that boosted profits while “artificially” ...3 days ago -
MarketWatch - Business
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’
Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, regulator alleges.3 days ago -
Financial Times - Business
Lammy accused of diplomatic blunder in Substack blog post
UK foreign secretary suggested Azerbaijan had ‘liberated’ the disputed territory of Nagorno-Karabakh3 days ago -
Financial Times - Business
Did central banks get the inflation crisis right?
Policymakers are lowering rates and signalling new confidence that a ‘soft landing’ is possible. But few are ready to declare victory3 days ago -
Financial Times - Business
US drug ‘gatekeepers’ face FTC antitrust lawsuit over insulin prices
Complaint alleges pharmacy benefit managers owned by CVS, Cigna and UnitedHealth are keeping prices high4 days ago -
The Wall Street Journal - Business
FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.4 days ago -
The Wall Street Journal - Business
FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.4 days ago -
BBC News - Top stories
McNally murder accused a master manipulator, court told
Stephen McCullagh is accused of murdering his pregnant partner in her Lurgan home.4 days ago -
The Wall Street Journal - Business
The Price War in Weight-Loss Drugs Is Here
Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price tags of over $1,000 a month.4 days ago -
The Wall Street Journal - Business
Social-Media Firms Lack Adequate Privacy Controls, FTC Report Says
The agency said the companies engaged in vast consumer surveillance while failing to provide adequate privacy controls or safeguards for children.5 days ago -
BBC News - Top stories
Mohamed Al Fayed accused of multiple rapes by staff
Five women who worked at the luxury store say they were raped by the billionaire - BBC documentary reveals.5 days ago
More from The New York Times
-
The New York Times - Health
Widowed and Looking for Love, Like the Golden Bachelorette
“The Golden Bachelorette” offers a glimpse at how dating changes after losing the love of your life. This is what it’s really like.2 days ago -
The New York Times - Health
Was It Really a Hot Zone Summer?
From Covid to dengue, viral outbreaks seemed to be popping up all over. But maybe Americans are just more attuned to threats now.Yesterday -
The New York Times - Health
Rethinking Addiction as a Chronic Brain Disease
Some researchers argue that the roles of social environment and personal choice have to be considered in order to make progress in treating people addicted to drugs.September 3 -
The New York Times - Health
What R.F.K. Jr.’s Alliance With Trump Could Mean for Public Health
Robert F. Kennedy Jr., who has long voiced doubts about vaccine safety, has hopes of influencing federal health policy. Could he finally get the chance?5 days ago - Donald Trump -
The New York Times - Health
Three Medical Practices That Older Patients Should Question
Some treatments and procedures become routine despite lacking strong evidence to show that they’re beneficial. Recent studies have called a few into question.September 14